Assignee
AMGEN INC
US1,642 patents
Top patents by PatentIndex Score
USD819198SMay 29, 2018
Autoinjector with removable cap
AMGEN INC80 citations99
US8034770B2Oct 11, 2011
FGF21 polypeptides comprising two or more mutations
AMGEN INC63 citations99
US8030457B2Oct 4, 2011
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC175 citations99
US7097834B1Aug 29, 2006
Osteoprotegerin binding proteins
AMGEN INC102 citations99
US6022884AFeb 8, 2000
Substituted pyridine compounds and methods of use
AMGEN INC207 citations99
US5843678ADec 1, 1998
Osteoprotegerin binding proteins
AMGEN INC138 citations99
USD1001272SOct 10, 2023
Autoinjector with removable cap
AMGEN INC37 citations98
USD922567SJun 15, 2021
Autoinjector with removable cap
AMGEN INC43 citations98
USD898189SOct 6, 2020
Autoinjector with removable cap
AMGEN INC50 citations98
USD886281SJun 2, 2020
Autoinjector
AMGEN INC49 citations98
USD883475SMay 5, 2020
Handheld drug delivery device
AMGEN INC56 citations98
USD878560SMar 17, 2020
Autoinjector with removable cap
AMGEN INC59 citations98
USD851754SJun 18, 2019
Autoinjector with removable cap
AMGEN INC69 citations98
USD830539SOct 9, 2018
Autoinjector
AMGEN INC81 citations98
USD827128SAug 28, 2018
Handheld drug delivery device
AMGEN INC72 citations98
USD814022SMar 27, 2018
Autoinjector with removable cap
AMGEN INC83 citations98
US9546203B2Jan 17, 2017
Aglycosylated Fc-containing polypeptides with cysteine substitutions
AMGEN INC34 citations98
US8859741B2Oct 14, 2014
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC51 citations98
US8829165B2Sep 9, 2014
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC76 citations98
US8361963B2Jan 29, 2013
Uses of FGF21 polypeptides comprising two or more mutations
AMGEN INC64 citations98
US7915391B2Mar 29, 2011
Humanized c-Kit antibody
AMGEN INC112 citations98
US7833527B2Nov 16, 2010
Methods of treating psoriasis using IL-17 Receptor A antibodies
AMGEN INC57 citations98
US7767206B2Aug 3, 2010
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
AMGEN INC76 citations98
US7667008B2Feb 23, 2010
Fibroblast growth factor-like polypeptides and variants thereof
AMGEN INC65 citations98
US7442778B2Oct 28, 2008
Modified Fc molecules
AMGEN INC140 citations98
US7364736B2Apr 29, 2008
Antibodies to OPGL
AMGEN INC97 citations98
US7138370B2Nov 21, 2006
Specific binding agents of human angiopoietin-2
AMGEN INC100 citations98
US6919426B2Jul 19, 2005
Peptides and related molecules that modulate nerve growth factor activity
AMGEN INC256 citations98
US6660843B1Dec 9, 2003
Modified peptides as therapeutic agents
AMGEN INC631 citations98
US6589758B1Jul 8, 2003
Crystal of a kinase-ligand complex and methods of use
AMGEN INC118 citations98
US6420339B1Jul 16, 2002
Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
AMGEN INC288 citations98
US6355267B1Mar 12, 2002
Liposome preparation and material encapsulation method
AMGEN INC103 citations98
US6316408B1Nov 13, 2001
Methods of use for osetoprotegerin binding protein receptors
AMGEN INC89 citations98
US6294170B1Sep 25, 2001
Composition and method for treating inflammatory diseases
AMGEN INC122 citations98
US6284485B1Sep 4, 2001
Nucleic acids encoding osteoprotegerin
AMGEN INC123 citations98
US6096728AAug 1, 2000
Composition and method for treating inflammatory diseases
AMGEN INC322 citations98
US6057124AMay 2, 2000
Nucleic acids encoding ligands for HEK4 receptors
AMGEN INC148 citations98
US6015572AJan 18, 2000
Implantable device containing GDNF secreting cells for treating nerve damage and methods of use
AMGEN INC137 citations98
US6015938AJan 18, 2000
Osteoprotegerin
AMGEN INC158 citations98
US5981245ANov 9, 1999
EPH-like receptor protein tyrosine kinases
AMGEN INC178 citations98
US5783186AJul 21, 1998
Antibody-induced apoptosis
AMGEN INC437 citations98
US5756349AMay 26, 1998
Production of erythropoietin
AMGEN INC330 citations98
US5354934AOct 11, 1994
Pulmonary administration of erythropoietin
AMGEN INC160 citations98
US4762779AAug 9, 1988
Compositions and methods for functionalizing nucleic acids
AMGEN INC820 citations98
USD985119SMay 2, 2023
Handheld drug delivery device
AMGEN INC47 citations97
USD886282SJun 2, 2020
Autoinjector with removable cap
AMGEN INC48 citations97
US10640504B2May 5, 2020
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC50 citations97
USD882071SApr 21, 2020
Autoinjector with removable autoinjector cap
AMGEN INC51 citations97
USD877892SMar 10, 2020
On-body injector for drug delivery
AMGEN INC56 citations97
US10532042B2Jan 14, 2020
KRAS G12C inhibitors and methods of using the same
AMGEN INC49 citations97
Showing the top 50 of 1,642 patents by PatentIndex Score.